| Product Name | MF | CAS | Details |
|---|
| 3-(Aminomethylene)-6-phenyl-2,5-piperazinedione | C11H11N3O2 | 65870-51-1 | Details |
| Paromamine 3HCl | C12H25N3O7 | 534-47-4 | Details |
| 1-Pyrenol acetate | C18H12O2 | 78751-40-3 | Details |
| Methyl 4-bromo-6-methylpyrimidine-2-carboxylate | C7H7BrN2O2 | 1508102-01-9 | Details |
| Mammaglobin A antibody | Details |
| PR-619 | C7H5N5S2 | 2645-32-1 | Details |
| DL-Penicillamine | C5H11NO2S | 52-66-4 | Details |
| CP 724714 | C27H27N5O3 | 383432-38-0 | Details |
| LYVE1 Blocking Peptide | Details |
| {[2-(Benzyloxy)phenyl]methyl}(methyl)amine hydrochloride | 1048674-37-8 | Details |
| 7-Methyl-5-nitro-1H-indole | C9H8N2O2 | 10553-08-9 | Details |
| 6-Chloro-5-(hydroxymethyl)pyridine-3-carbonitrile | C7H5ClN2O | 1360944-06-4 | Details |
| tert-Butyl 5-aminoazocane-1-carboxylate | C12H24N2O2 | 1174020-27-9 | Details |
| 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl-Fmoc serine | C32H36N2O13 | 160067-63-0 | Details |
| 2-(1-{[(tert-Butoxy)carbonyl]amino}cyclopropyl)pyrimidine-5-carboxylic acid | C13H17N3O4 | 2091298-49-4 | Details |
| 7-Fluoro-5-methoxy-2,3-dihydro-1H-inden-1-one | C10H9FO2 | 1199782-74-5 | Details |
| FDXR Blocking Peptide | Details |
| VTN Blocking Peptide | Details |
| Methyl 4-amino-6-chloronicotinate | C7H7ClN2O2 | 1256785-40-6 | Details |
| (2-Methoxyethyl)(3-methoxypropyl)amine | C7H17NO2 | 171274-03-6 | Details |
| 2-[(5-Bromo-1,3-thiazol-2-yl)methyl]-2,3-dihydro-1H-isoindole-1,3-dione | C12H7BrN2O2S | 2060008-44-6 | Details |
| 5-Nitro-3-pyrazolecarboxylic acid | C4H3N3O4 | 198348-89-9 | Details |
| CSRP1 antibody | Details |
| CLK1 antibody | Details |
| 6-Amino-1-(2-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione | C11H11N3O3 | 180028-89-1 | Details |
| 2-Naphthalenethiol | C10H8S | 91-60-1 | Details |
| 2-[(2-Amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-aminopropanoate | C11H16N6O4 | 84499-64-9 | Details |
| SLC26A8 antibody | Details |
| (p-Sec-butylphenyl)acetic acid | C12H16O2 | 1977-39-5 | Details |
| 4-Pentynoic acid | C5H6O2 | 6089-09-4 | Details |
| Lipoamide-PEG3-Mal | C25H41N3O7S2 | 1314378-19-2 | Details |
| Hedychenone | C20H26O2 | 56324-54-0 | Details |
| 3-Benzyl-7-cyclopentyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione | C17H18N4O2 | 565172-46-5 | Details |
| 2-(Chloromethyl)-5-cyclopropyl-1,3-oxazole | C7H8ClNO | 1225058-34-3 | Details |
| alpha-Chloro-4-fluorobenzaldehyde oxime | C7H5ClFNO | 42202-95-9 | Details |
| KN 93 phosphate | C26H32ClN2O8PS | 1188890-41-6 | Details |
| TATDN1 antibody | Details |
| (1S)-1-[3-Fluoro-4-(1H-pyrazol-1-yl)phenyl]ethan-1-ol | C11H11FN2O | 1344920-32-6 | Details |
| 2'-(Dibenzylamino)-6'-(diethylamino)fluoran | C38H34N2O3 | 34372-72-0 | Details |
| 4-(3-Chlorophenoxy)benzene-1-sulfonyl chloride | C12H8Cl2O3S | 815576-24-0 | Details |
| Syndecan 4 protein | Details |
| 13-O-Desmethyl tacrolimus | C43H67NO12 | 139958-51-3 | Details |
| VU 0422288 | C17H11Cl2N3O2 | 1630936-95-6 | Details |
| Fumonisin B1 | C34H59NO15 | 116355-83-0 | Details |
| Glucagon (1-29), bovine, human, porcine | C153H225N43O49S | 16941-32-5 | Details |
| Etokimab | 2022981-44-6 | Details |
| L-Gulonic acid-1,4-lactone | C6H10O6 | 1128-23-0 | Details |
| ARRB1 antibody | Details |
| 3,4-Difluoro-2-methylphenylboronic acid pinacol ester | C13H17BF2O2 | 1025707-97-4 | Details |
| 5-Bromo-4-hydrazinylpyrimidine | C4H5BrN4 | 859206-99-8 | Details |
| Pimecrolimus | C43H68ClNO11 | 137071-32-0 | Details |
| Cytidine hemisulfate salt | C18H28N6O14S | 6018-48-0 | Details |
| Peroxydehydrotumulosic acid | C31H46O6 | 943225-53-4 | Details |
| GUCY1A3 antibody | Details |
| 4-Bromobutan-2-ol | C4H9BrO | 6089-17-4 | Details |
| Methyl 1-acetylcyclobutane-1-carboxylate | C8H12O3 | 1540220-96-9 | Details |
| 4-Amino-1-methyl-1H-pyrazole-5-carboxamide hydrochloride | C5H9ClN4O | 939979-31-4 | Details |
| Myosin 9 antibody | Details |
| ZNF136 antibody | Details |
| 6-Methyl-2-(2-pyrrolidinyl)-1H-benzimidazole dihydrochloride | C12H16ClN3 | 1185692-43-6 | Details |
| Ku80 antibody | Details |
| Ethyl 5-(4-chlorophenyl)-1H-1,2,4-triazole-3-carboxylate | C11H10ClN3O2 | 62230-51-7 | Details |
| ((2-indol-3-ylethyl)amino)((4-nitrophenyl)amino)methane-1-thione | C17H16N4O2S | 362502-77-0 | Details |
| 5-Chloro-7-methyl-1H-indole-3-carbaldehyde | C10H8ClNO | 15936-83-1 | Details |
| 3-Cycloheptylpiperidine | C12H23N | 1566325-54-9 | Details |
| PDGFRa antibody (Tyr849) | Details |
| 1-Bromo-4-(but-2-en-1-yloxy)benzene | C10H11BrO | 1017091-66-5 | Details |
| 4-Chloro-8-nitroquinazoline | C8H4ClN3O2 | 19815-18-0 | Details |
| 2-Methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-one | C12H14O2 | 40463-28-3 | Details |
| Trimethyl(2-oxoethyl)azanium hydrate chloride | C5H12NO.Cl.H2O | 92397-80-3 | Details |
| 2-Methyl-2-phenoxypropanoyl chloride | C10H11ClO2 | 50389-29-2 | Details |
| 3-(Ethoxycarbonyl)-1-methyl-1H-pyrazole-4-carboxylic acid | C8H10N2O4 | 1174830-89-7 | Details |
| Ethyl 4-hydroxy-2,5,6-trimethylpyridine-3-carboxylate | C11H15NO3 | 1803262-21-6 | Details |
| 1-Allyl-[1,4]diazepane | C8H16N2 | 229162-11-2 | Details |
| STAC3 antibody | Details |
| 4,5-Dimethylthiophene-2-sulfonamide | C6H9NO2S2 | 140646-53-3 | Details |
| Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate | C6H6N2O3 | 89640-81-3 | Details |
| Benzyl[1-(pyridin-2-yl)ethyl]amine | C14H16N2 | 1019482-76-8 | Details |
| 4,4,5,5-Tetramethyl-2-(3-propylphenyl)-1,3,2-dioxaborolane | C15H23BO2 | 1402884-05-2 | Details |
| N-(Piperidin-4-yl)morpholine-4-carboxamide dihydrochloride | C10H20ClN3O2 | 1909317-15-2 | Details |
| Spiromesifen-alcohol-4-hydroxymethyl | C17H20O4 | 873423-07-5 | Details |
| STEAP1 antibody (FITC) | Details |
| Cytokeratin 1 Blocking Peptide | Details |
| 3-Methyl-1,2,5,6,7,8-hexahydroquinoxalin-2-one | 118136-71-3 | Details |
| TGN1412 | Details |
| 5-(2-Methoxy-5-methylphenyl)-5-methylimidazolidine-2,4-dione | C12H14N2O3 | 1052564-21-2 | Details |
| 1-tert-Butyl 3-ethyl 4,5-dihydro-1H-pyrrole-1,3-dicarboxylate | C12H19NO4 | 188528-94-1 | Details |
| Ethyl 3-(1-ethyl-1H-pyrazol-4-yl)-3-oxopropanoate | C10H14N2O3 | 1216162-03-6 | Details |
| 4-[(Dimethylamino)methyl]oxolan-3-one hydrochloride | 2138146-01-5 | Details |
| 6-(Pyrrolidin-1-yl)pyridine-3-carboximidamide dihydrochloride | C10H15ClN4 | 1394718-44-5 | Details |
| 3-Hydrazinyl-6-[3-(trifluoromethyl)phenyl]pyridazine | C11H9F3N4 | 76970-16-6 | Details |
| 5-Chloro-2-(cyclopentylsulfanyl)benzoic acid | C12H13ClO2S | 1342701-58-9 | Details |
| HAV IgM Positive Human Plasma | Details |
| ML 352 | C21H29N3O4 | 1649450-12-3 | Details |
| 5-Bromo-2-ethyl-3,4-dihydropyrimidin-4-one | C6H7BrN2O | 1528580-99-5 | Details |
| tert-Butyl 2-(aminomethyl)-3-methylbutanoate | C10H21NO2 | 1486181-00-3 | Details |
| 1-[3-(1H-1,2,3-Triazol-1-yl)phenyl]ethan-1-one | C10H9N3O | 85862-97-1 | Details |
| 4,8-Dichloro-5-methoxy-2-methylquinoline | C11H9Cl2NO | 1206-61-7 | Details |
| VPS29 Blocking Peptide | Details |
| Physalin G | C28H30O10 | 76045-38-0 | Details |
| Product Total： Product Page： | ||||
| 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 | ||||